Hepatitis C virus (HCV) infects 180 million people worldwide and over 4 million people in
the United States. HCV infection is a major cause of chronic liver disease and is recognized …

Hepatitis C virus (HCV) infects primarily hepatocytes, leads to development of fibrosis and/or
cirrhosis of the liver and is a significant factor for developing hepatocellular carcinoma …

Background The objective of the study was to evaluate the serum levels of tumour necrosis
factor (TNF)‐α, interleukin (IL)‐1β and IL‐6 in chronic HBV‐infected patients. Methods The …

Background The pathogenesis of inflammatory bowel disease (IBD) is associated with a
dysregulated mucosal immune response. Certain stimulators of innate immunity (CpG DNA …

Human Hepatitis B Virus Negatively Impacts the Protective Im... : Hepatology Human Hepatitis B
Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic …

Up to one in four patients infected with human immunodeficiency virus type 1 and given
antiretroviral therapy (ART) experiences inflammatory or cellular proliferative disease …

Abstract Background/Objectives Beta (β)-thalassemia adults are prone to premature
atherosclerosis but data about this complication among thalassemia children are few …

Toll-like receptors (TLRs) are key mediators of innate immunity, and their activation by
microbial components leads to the production of cytokines and interferons. Recombinant …

Background Non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-
alcoholic steatohepatitis (NASH), are among the least understood metabolic consequences …

Methods: A total of 390 subjects (145 controls, 62 inactive HBV-carriers, 64 chronic-active
HBV patients, 60 HBV related cirrhotics and 59 HBV-HCC subjects) were enrolled in the …